Nurix Therapeutics (NRIX) Enterprise Value (2019 - 2026)
Nurix Therapeutics (NRIX) reported Enterprise Value of -$540.7 million for Q1 2026, up 1.63% year-over-year from -$532.1 million in Q1 2025, and up 8.81% quarter-over-quarter from -$592.9 million in Q4 2025.
Nurix Therapeutics (NRIX) Enterprise Value (2019 - 2026) Analysis & Trends
Nurix Therapeutics (NRIX) has 8 years of Enterprise Value data on file, last reported at -$540.7 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$540.7 million, up 1.63% year-over-year; the trailing twelve-month figure through Feb 2026 was -$540.7 million (up 1.63% YoY), and the FY2025 annual result was -$592.9 million, up 2.73% from the prior year.
- Enterprise Value advanced to -$540.7 million in Q1 2026 per NRIX's latest filing, from -$592.9 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$244.0 million in Q1 2024 and troughed at -$609.6 million in Q4 2024.
- A 5-year average of -$391.8 million and a median of -$344.5 million in 2022 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value gained 24.86% in 2023, then sank 125.29% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$309.1 million in 2022, then advanced by 6.87% to -$287.9 million in 2023, then tumbled by 111.73% to -$609.6 million in 2024, then climbed by 2.73% to -$592.9 million in 2025, then gained by 8.81% to -$540.7 million in 2026.
- Business Quant data shows NRIX's Enterprise Value at -$540.7 million in Q1 2026, -$592.9 million in Q4 2025, and -$428.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Nurix Therapeutics | 1.93 Bn | 1.39 Bn | - | -540.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -540.73 Mn |
| Nov 30, 2025 | -592.94 Mn |
| Aug 31, 2025 | -428.83 Mn |
| May 31, 2025 | -485.78 Mn |
| Feb 28, 2025 | -549.68 Mn |
| Nov 30, 2024 | -609.58 Mn |
| Aug 31, 2024 | -448.05 Mn |
| May 31, 2024 | -443.14 Mn |
| Feb 29, 2024 | -243.99 Mn |
| Nov 30, 2023 | -287.91 Mn |
| Aug 31, 2023 | -258.85 Mn |
| May 31, 2023 | -281.18 Mn |
| Feb 28, 2023 | -277.15 Mn |
| Nov 30, 2022 | -309.14 Mn |
| Aug 31, 2022 | -344.48 Mn |
| May 31, 2022 | -297.28 Mn |
| Feb 28, 2022 | -261.98 Mn |
| Nov 30, 2021 | -295.72 Mn |
| Aug 31, 2021 | -343.90 Mn |
| May 31, 2021 | -386.02 Mn |